
Our Platforms
We build our platforms harnessing advances in microfluidics and AI.
Bringing miniaturization, automation and scalability revolutionizes how we develop and manufacture tangible products in multiple industries. Microfluidics and AI can vastly improve the manipulation or observation of any material assets, whether alive or not. Explore the list of our current platforms below and request new features. Perhaps they are already in the works! ;)
Meet Our Most Advanced Platform
The Infinity Screening System
One Platform for Both
Discovery and Validation
The Infinity Screening System is one platform for high-throughput in vivo safety, efficacy, and performance studies. INFINITY 2.0 is our light-speed engine for both science-backed ingredient discovery and validation. Our platform has been validated with many ingredient classes, and those that have safe history of use are entering into first-in-human clinical trials with novel health claims.
We use the planet’s best studied organism to deliver human-relevant biological data
The microscopic worm C. elegans is an invertebrate and does not feel pain in the same way that mammals do, enabling ethical and cruelty-free evaluation of ingredients. The biology of C. elegans is highly conserved with humans in terms of genetics and signaling pathways. We know more about the biology of C. elegans than any animal on the planet, providing a large knowledge base for understanding the effect of ingredients.

C. elegans consume only less than 1 ng of food per day, which 300x less than a mouse. This saves ingredient usage.

Our patented microfluidic technology enables scalable worm husbandry and efficient ingredient delivery
Machine vision cameras record simultaneously, the worm response to multiple ingredient conditions.
Deep neural networks and edge computing enable on-the-fly analysis of videos to extract contextual data at scale.
The experimental paradigm determines the data output for a given ingredient. Measures range from simple endpoints such as all-cause mortality to complex behavioral maps to activity-based health readouts.
3D Image of our chip
Our AI computation analyzes videos at scale, digitizing the worm’s response to ingredients
Machine vision cameras record simultaneously, the worm response to multiple ingredient conditions.
Deep neural networks and edge computing enable on-the-fly analysis of videos to extract contextual data at scale.
The experimental paradigm determines the data output for a given ingredient. Measures range from simple endpoints such as all-cause mortality to complex behavioral maps to activity-based health readouts.
Our Innovative Solution
Tractable Organism
+
Microfluidic Automation
+
AI Computation